Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Boehringer Ingelheim Research Institute of Molecular Pathology (IMP)

Project Type

Research centre

Location

Vienna, Austria

Construction Started

March 2015

Expected Completion

End of 2016

Estimated Investment

€50m ($54.53m)

Designed by

ATP architects and engineers

Construction Contractor

PORR

Sponsor

Boehringer Ingelheim
Expand

Go Top